Standard Chemical & Pharmaceutical Co Ltd (1720)

Taiwan

Currency in TWD

57.40

0.00(0.00%)

Closed·01/08

Fair Value

Unlock Value

Day's Range

56.30

57.50

52 wk Range

51.20

68.00

1720 Financial Summary

A brief financial summary of Standard Chemical & Pharmaceutical Co Ltd as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio12.57

Price/Book1.84

Debt / Equity7.39%

Return on Equity14.82%

Dividend Yield4.88%

EBITDA1.77B

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

4,305.4

4,604.08

5,851.37

6,239.77

6,789.22

Gross Profit

aa.aa

1,919.84

2,067.87

2,487.61

2,725.38

2,988.69

Operating Income

aa.aa

706.63

876.83

1,118.32

1,259.53

1,396.51

Net Income

aa.aa

524.17

706.73

815.41

834.89

880.5

Balance Sheet

Total Assets

aa.aa

7,049.45

10,095.04

10,968.26

11,188.72

11,175.55

Total Current Liabilities

aa.aa

1,650.62

2,716.1

2,879.83

2,370.88

1,660.93

Total Equity

aa.aa

4,905.84

6,799.61

7,435.6

8,137.34

8,976.07

Cash Flow

Levered Free Cash Flow

aa.aa

251.92

-89.85

-125.88

437.13

598.97

Cash from Operations

aa.aa

922.58

827.03

1,227.83

1,336.52

1,694.94

Cash from Investing

aa.aa

-710.17

819.12

-1,080.83

-485.51

-771.69

Cash from Financing

aa.aa

-643.98

-117.54

-465.44

-1,076.13

-1,444.31

Net Change in Cash

aa.aa

-435.72

1,528.21

-305.01

-222.64

-516.62

* In Millions of TWD (except for per share items)

Dividends

Payout Ratio

Payout ratio (TTM)

Earnings retained

EPS 4.60%

Dividend Yield

4.88%

Industry Median 2.54%

Annualised payout

2.80

Paid annually

5-Years Growth

+13.30%

Growth Streak

Unlock

Analyst Ratings

1 Buy

0 Hold

0 Sell

Ratings:

1 analysts

Overall Consensus

Buy

Analysts 12-Month Price Target:

Average 73.00

(+27.18% Upside)

Earnings

Latest Release

May 07, 2025

EPS / Forecast

1.12 / --

Revenue / Forecast

1.64B / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were SCPC's earnings for the latest quarter?

The SCPC EPS (TTM) is 4.60. SCPC reported sales of 1,640.03, net income of 194.67, and EPS of 1.12 for the latest quarter.

What was SCPC's net income for the latest quarter?

SCPC's net income for the latest quarter was 194.67.

How did SCPC's performance compare year-over-year in the latest quarter?

The company's revenue moved from 1,673.14 in the previous quarter to 1,640.03 in the latest quarter, and net income moved from 194.64 to 194.67 compared to the previous quarter.

What is SCPC's net profit margin on a TTM basis?

SCPC's trailing twelve months (TTM) net profit margin is 12.97%.

How does SCPC's debt to equity ratio compare to industry standards?

SCPC's total debt-to-equity ratio is 7.39%.

What is SCPC's return on investment on a TTM basis?

SCPC's trailing twelve months (TTM) return on investment (ROI) is 14.82%.

Did SCPC gain or lose cash last quarter?

In the latest quarter, SCPC's net change in cash was 114.35 million.

What were SCPC's total assets and liabilities in the latest quarter?

As of the latest quarter, SCPC reported total assets of 11,413.46 million and total liabilities of 2,469.56 million.

How has SCPC's total revenue grown this year?

SCPC's total revenue was 1,673.14 in the previous quarter and 1,640.03 in the latest quarter.

What is SCPC's gross margin on a TTM basis?

SCPC's trailing twelve months (TTM) gross margin is 43.63%.

What was SCPC's revenue per share for the latest quarter?

SCPC's revenue per share for the latest quarter was 22.77.

NSE 30

5,185.55

+49.87

+0.97%

NSE All Share

141,263.05

+1,399.53

+1.00%

US 30

43,577.00

-554.0

-1.26%

US 500

6,235.60

-103.9

-1.64%

FTSE 100

9,068.58

-64.23

-0.70%

DAX

23,425.97

-639.50

-2.66%

South Africa Top 40

90,140.55

-640.82

-0.71%

Market Movers

Name	Last	Chg. %	Vol.
Fcmb	10.800	+8.00%	277.21M
Fidelitybk	21.200	+0.71%	85.55M
Zenith Bank	76.50	0.00%	38.61M
UBA	49.25	-0.71%	28.79M
Guaranty Trust Holding	99.50	-1.00%	26.28M
Lafarge Africa	149.00	0.00%	9.23M
Aradel Holdings	520.00	-1.89%	6.28M

Name	Last	Chg. %	Vol.
UAC Of Nigeria	88.30	+9.96%	3.53M
BUA Cement	148.00	+9.63%	2.84M
Veritas Kapital	1.39	+9.45%	41.54M
Betaglas	408.50	+9.22%	839.96K
Wema Bank	23.90	+8.64%	19.51M
Prestige	1.26	+8.62%	7.19M
Custodian Allied	39.00	+8.33%	752.29K

Name	Last	Chg. %	Vol.
Champion Brew	12.51	-10.00%	6.95M
Oando Plc	53.10	-10.00%	10.38M
Dangote Sugar	66.15	-10.00%	4.68M
Cornerst	4.15	-9.78%	2.49M
Abbey Mortgage Bank	5.27	-9.76%	460.62K
International Energy Insurance	2.13	-9.75%	1.22M
University Pre	5.100	-9.73%	908.00K

Trending Stocks

Name	Last	Chg. %	Vol.
UBA	49.25	-0.71%	28.79M
MTN Nigeria	480.00	+1.69%	1.49M
Betaglas	408.50	+9.22%	839.96K
Fidelitybk	21.200	+0.71%	85.55M
VFD PLC	13.90	0.00%	20.33M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaa Aa	528.30	+38.64%	732.44
Aa Aaa A	67.00	+24.26%	83.25

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Standard Chemical & Pharmaceutical Co Ltd (1720)

1720 Financial Summary

Key Ratios

Statements Highlights

Dividends

Analyst Ratings

Analysts 12-Month Price Target:

Earnings

FAQ

What were SCPC's earnings for the latest quarter?

What was SCPC's net income for the latest quarter?

How did SCPC's performance compare year-over-year in the latest quarter?

What is SCPC's net profit margin on a TTM basis?

How does SCPC's debt to equity ratio compare to industry standards?

What is SCPC's return on investment on a TTM basis?

Did SCPC gain or lose cash last quarter?

What were SCPC's total assets and liabilities in the latest quarter?

How has SCPC's total revenue grown this year?

What is SCPC's gross margin on a TTM basis?

What was SCPC's revenue per share for the latest quarter?

Trending Stocks